iMEDCAP: European project to pioneer the rescue of wounded soldiers from inaccessible areas

Feb 22, 2024 | News, Press Release

iMEDCAP: How an innovative European project shall pioneer the rescue of wounded soldiers from inaccessible areas

In December, the project iMEDCAP, funded by the European Defence Fund, was kicked-off. With its user-driven, holistic approach, the flagship iMEDCAP sets out to revolutionize the emergency detection, identification, extraction, treatment, and evacuation of gravely injured and possibly contagious personnel in a completely autonomous way.

Credits: This rescue drone will be part of the autonomous evacuation and rescue strategy. ©Avilus

Funded by the European Defence Fund (EDF) and in collaboration with a robust consortium of esteemed European partners, ARTTIC Innovation GmbH is proud to announce the launch of the iMEDCAP project with its kick-off meeting held in Garching, Germany, on 13/14 December 2023. This innovative project, led by Technische Universität München as the Coordinator, brings together a diverse array of 24 organizations from 9 countries, uniting European expertise and resources to pioneer ground-breaking advancements in military healthcare and emergency response capabilities.

Over the last decade, significant progress has been made in the development of autonomous air and ground transport, detection technologies as well as (remote) medical interventions. These developments reveal both the potential and the necessity to modernize and adapt rescue systems to facilitate evacuation from complex and/or dangerous situations. Novel weapon technologies have led to several paradigm changes of the situation of ground forces, influencing the requirements for ad hoc medical support and transport logistics. In scenarios, decentral medical support will be needed in a potentially hostile environment, including CBRN (Chemical, Biological, Radiological, Nuclear) threats. Current medical evacuation solutions are limited both in their available numbers and their usability in CBRN situations which contradicts the medical paradigm of the “golden hour” postulating immediate response to traumatic injury to guarantee the highest possible survival rates. A holistic and innovative approach is needed to enhance Europe’s preparedness.

In response to these needs, the user-driven concept of iMEDCAP sets out to design and develop a rescue system which facilitates the autonomous detection of injured personnel, the automatic definition of an evacuation and rescue strategy and an initial treatment in an interoperable patient box, equipped with diagnostic and intervention equipment, during transport under remote control. iMEDCAP brings together partners from the armed forces, universities, small and medium sized entities and industrial partners, sharing their expertise in their research fields and advancing their technologies and know-how towards a sophisticated solution. The final outcome of iMEDCAP will be the validation of the components and a roadmap for further development, laying the foundations for a modern and digital European rescue system.

While the iMEDCAP project is initiated in the defence sector, technical developments will reveal huge potential for intelligent solutions, facilitating autonomous rescue approaches not only limited to military scenarios, but also covering civil emergency scenarios like wildfire or nuclear incidents.

The iMEDCAP project

The iMEDCAP project started on 1st December 2023 and will run for 36 months. It unites partners from the armed forces, universities, small and medium sized entities and industrial partners: Technical University Munich (DE), Sanitätsakademie der Bundeswehr, Armed Forces of Germany and Austria (DE, AT), Institute for Pharmacology and Toxicology of the German Armed Forces (DE), Institute for Radiobiology of the German Armed Forces (DE), Autoflug GmbH (DE), Philips Electronics Nederland BV (NL), Philips GmbH (DE), Safran Electronics & Defense (FR), Avilus GmbH (DE), Composite Project Kft (HU), EMBENTION Sistemas Inteligentes SA (ES), GRABHER Group GmbH (AT), MGM COMPRO S.R.O. (CZ), MILREM Robotics (EE), VITALSIQ BV (NL), Sol1 (BE), SYNYO GmbH (AT), Virtual Vehicle Research GmbH (AT), Joanneum Research Forschungsgesellschaft mbH (AT), Klinikum rechts der Isar der Technischen Universitat Munchen (DE), University of Stuttgart (DE), ARTTIC Innovation GmbH (DE).

About European Defence Fund:

The European Defence Fund (EDF) is a multiannual framework programme that supports competitive and collaborative projects through the entire cycle of research and development for a bigger impact on the European defence capability and industrial landscape. It promotes the cooperation among companies and research actors of all sizes and geographic origin in the European Union and Norway, in research and development state of the art and interoperable defence technology and equipment. More information to be found at https://defence-industry-space.ec.europa.eu/

iMEDCAP Contact

Project Management:
Dr. Sabine Possmann, ARTTIC Innovation GmbH, sabine.possmann@arttic-innovation.de

Press Relations:
Verena von Scharfenberg, ARTTIC Innovation GmbH, press@arttic-innovation.de

iMEDCAP is funded by the European Union under Grant Agreement Number 101121421.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.

ARTTIC Innovation GmbH has been advising research and innovation projects for more than 33 years. As project management and communication partner, we make sure that our projects run successfully and that project results and events are disseminated in the best possible way. ARTTIC is a subsidiary of the PNO Group, one of the largest consultancies for publicly funded projects in research and development. For more information, please visit www.arttic-innovation.de.

Junior Funding Consultant (m/f/d)

Junior Funding Consultant (m/f/d)

We offer you the unique opportunity to become part of a successful & young team in the attractive growth market for tax-incentivised research funding (R&D tax credits).  We are looking for Junior Funding Consultants with a passion for innovation, scientific...

read more
First successful demonstration with 100% green H2

First successful demonstration with 100% green H2

HYFLEXPOWER celebrates successful operation of a gas turbine with 100% green H2On October 12, 2023, at a public event hosted at the HYFLEXPOWER demonstrator site in Saillat-sur-Vienne, France, the HYFLEXPOWER consortium unveiled a ground-breaking achievement - the...

read more
SYNERGISE for Improved Disaster Management

SYNERGISE for Improved Disaster Management

Internationally Funded Project to Develop an Integrated Toolkit for Improved Management of Natural and Man-Made Disasters Kicks-Off TodayTo boost the efficiency and safety of first responders during life-saving missions, the SYNERGISE team will develop a Novel...

read more
Junior Innovation Consultant (m/f/d)

Junior Innovation Consultant (m/f/d)

We offer you the unique opportunity to become part of a dynamic team in the attractive field of innovation and research. We are looking for Innovation Consultants with a passion for innovation, scientific writing and project management. This position is for recent...

read more
Senior Innovation Consultant (m/f/d)

Senior Innovation Consultant (m/f/d)

We offer you the unique opportunity to become part of a dynamic team in the attractive field of innovation and research. We are looking for specialists with a passion for innovation, scientific writing and project management. This position is for experienced...

read more
Business Developer (m/f/d)

Business Developer (m/f/d)

We are looking for specialists in business development with a strong sales talent and an interest in innovation, research and science. This position is for recent graduates or experienced professionals and involves assisting clients from a variety of industries with...

read more
CARAMBA: New Hope for Multiple Myeloma Patients

CARAMBA: New Hope for Multiple Myeloma Patients

CARAMBA: the European pioneer for virus-free CAR-T cell immunotherapy against multiple myelomaOn 30th June 2023, the EU-funded project CARAMBA is coming to an end, marking five years of challenges and successes in the mission to revolutionise multiple myeloma...

read more